Literature DB >> 22014042

Epithelial-mesenchymal interactions in breast cancer: evidence for a role of nuclear localized β-catenin in carcinoma-associated fibroblasts.

Eldo T Verghese1, Hrishikesh Shenoy, Victoria J Cookson, Caroline A Green, Jo Howarth, R H Partanen, Steven Pollock, Alison Waterworth, Valerie Speirs, Thomas A Hughes, Andrew M Hanby.   

Abstract

AIMS: Characteristics of the stroma around tumours are critical in defining the behaviour of cancers. β-Catenin is well established as a critical regulator of carcinogenesis, acting as a transcriptional co-activator in the nuclei of epithelial cancer cells. We have examined the prevalence and influence of nuclear β-catenin within the stromal fibroblasts of breast cancer. METHODS AND
RESULTS: We examined β-catenin expression in 201 breast cancers and adjacent normal tissue. Fibroblasts expressing nuclear β-catenin were present in a significantly greater proportion of tumour tissues than normal tissues. The presence of fibroblasts with nuclear β-catenin in tumours correlated with survival; tumours with prevalent positive fibroblasts were associated significantly with relatively good prognoses. Functional studies to examine influences of fibroblasts with nuclear β-catenin, showed fibroblasts transfected to allow overexpression of β-catenin were capable of inducing increases in both proliferation and invasion of breast cancer cell lines.
CONCLUSION: The presence of fibroblasts with nuclear β-catenin in tumours is a good prognostic indicator, although in the context of tissue culture models these cells can increase the growth and metastatic potential of cancer cells. These apparently paradoxical observations underline the complexity of epithelial-stromal signalling within tumours and highlight an area for further study. 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014042     DOI: 10.1111/j.1365-2559.2011.03917.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

Review 1.  Multiple oncogenic roles of nuclear beta-catenin.

Authors:  Raju Kumar; Murali D Bashyam
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

2.  Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases.

Authors:  Teng Hou; Dongxia Liang; Jiehua He; Xu Chen; Yanna Zhang
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

Review 3.  Pharmacological modulation of beta-catenin and its applications in cancer therapy.

Authors:  Ravi Thakur; Durga Prasad Mishra
Journal:  J Cell Mol Med       Date:  2013-03-14       Impact factor: 5.310

4.  MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.

Authors:  Eldo T Verghese; Ruth Drury; Caroline A Green; Deborah L Holliday; Xiaomei Lu; Claire Nash; Valerie Speirs; James L Thorne; Helene H Thygesen; Alexandre Zougman; Mark A Hull; Andrew M Hanby; Thomas A Hughes
Journal:  J Pathol       Date:  2013-11       Impact factor: 7.996

5.  Dermal fibroblasts induce cell cycle arrest and block epithelial-mesenchymal transition to inhibit the early stage melanoma development.

Authors:  Linli Zhou; Kun Yang; R Randall Wickett; Yuhang Zhang
Journal:  Cancer Med       Date:  2016-04-06       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.